We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Sensyne Health Plc | LSE:SENS | London | Ordinary Share | GB00BYV3J755 | ORD 10P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 0.35 | 0.30 | 0.40 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From May 2019 to May 2024
TIDMSENS
RNS Number : 1647B
Sensyne Health PLC
06 October 2020
Annual Report and Accounts and Notice of Annual General Meeting
Oxford, U.K. 06 October 2020 : Sensyne Health plc (LSE: SENS) ("Sensyne" or the "Company" or the "Group"), the UK Clinical AI company, announces that its Annual Report and Accounts for the year ended 30 April 2020 is now available on the Group's website at https://www.sensynehealth.com/investors/investor-hub
Copies of the Annual Report and Accounts will be posted later today to those shareholders that have elected to receive paper communications.
The Company also announces that its Notice of Annual General Meeting has been posted to shareholders today. The Annual General Meeting will be held virtually on 30 October 2020 at 1400 GMT.
As a result of current public health advice and "Stay at Home" guidance, the Company wishes to notify its shareholders that physical attendance in person at the AGM will not be possible.
-ENDS-
For more information please contact:
Sensyne Health ( www.sensynehealth.com +44 (0) 330 058 ) 1845 Lord (Paul) Drayson PhD FREng FMedSci, Chief Executive Officer Michael Norris, Interim Chief Financial Officer Consilium Strategic Communications +44 (0) 7780 600290 Mary-Jane Elliott Sukaina Virji Melissa Gardiner CSC sensynehealth@consilium-comms.com
About Sensyne Health
Sensyne Health plc is a clinical AI company that works in partnership with the NHS to improve patient care and accelerate the discovery and development of new medicines. Sensyne Health is listed on the AIM Market of the London Stock Exchange (SENS.L).
For more information, please visit: www.sensynehealth.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
ACSKKPBNDBDBOKK
(END) Dow Jones Newswires
October 06, 2020 02:00 ET (06:00 GMT)
1 Year Sensyne Health Chart |
1 Month Sensyne Health Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
